Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 10
Submit an article Journal homepage
168
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Retroperitoneal fibrosis as extramedullary hematopoiesis of a chronic myelomonocytic leukemia

Laure RicardService de médecine interne, UPMC, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France;
,
Noémie AbisrorService de médecine interne, UPMC, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France;
,
Nathalie DroinDépartement d’hématologie, Institut Gustave Roussy, Université Paris Sud, Villejuif, Paris, France; ;INSERM U1170, Gustave Roussy, Université Paris-Sud, Villejuif, Paris, France;
,
Dorothée Selimoglu-BuetDépartement d’hématologie, Institut Gustave Roussy, Université Paris Sud, Villejuif, Paris, France; ;INSERM U1170, Gustave Roussy, Université Paris-Sud, Villejuif, Paris, France;
,
Antoine MartinService d’Anatomopathologie, Université Paris 13 Hôpital Avicenne Bobigny, Paris, France;
,
Michael SoussanService de Médecine Nucléaire, Université Paris 13 Hôpital Avicenne Bobigny, Paris, France;
,
Christophe WillekensDépartement d’hématologie, Institut Gustave Roussy, Université Paris Sud, Villejuif, Paris, France;
,
Christophe DelignyService de Médecine interne, CHU de Martinique, Fort de France, Martinique, France
,
Olivier FainService de médecine interne, UPMC, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France;
,
Eric SolaryDépartement d’hématologie, Institut Gustave Roussy, Université Paris Sud, Villejuif, Paris, France; ;INSERM U1170, Gustave Roussy, Université Paris-Sud, Villejuif, Paris, France;
,
Arsène MekinianService de médecine interne, UPMC, AP-HP, Hôpital Saint Antoine, Sorbonne University, Paris, France; Correspondence[email protected]
& at the behalf MINHEMON (French network of dysimmune disorders associated to hemopathies) show all
Pages 2503-2505 | Received 19 Jun 2017, Accepted 28 Dec 2017, Published online: 25 Jan 2018

References

  • Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367:241–251.
  • Thomas MH, Chisholm GD. Retroperitoneal fibrosis associated with malignant disease. Br J Cancer. 1973;28:453–458.
  • Rockey DC, Bell PD, Hill JA. Fibrosis-a common pathway to organ injury and failure. N Engl J Med. 2015;372:1138–1149.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
  • Selimoglu-Buet D, Wagner-Ballon O, Saada V, Francophone Myelodysplasia Group, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125:3618–3626.
  • Merlevede J, Droin N, Qin T, et al. Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents. Nat Commun. 2016;7:10767.
  • Itzykson R, Kosmider O, Renneville A, et al. Clonal architecture of chronic myelomonocytic leukemias. Blood. 2013;121:2186–2198.
  • Braun T, Itzykson R, Renneville A, Groupe Francophone des Myélodysplasies, et al. Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial. Blood. 2011;118:3824–3831.
  • Mekinian A, Grignano E, Braun T, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology. 2016;55:291–300.
  • Grignano E, Mekinian A, Braun T, GFM, SNFMI and CRI, et al. Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review. Leuk Res. 2016;47:136–141.
  • Padron E, Steensma DP. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies. Curr Opin Hematol. 2015;22:163–170.
  • Fraison JB, Mekinian A, Grignano E, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–17.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.